A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million
|
|||||
 One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
The success of mobile devices depends on their underlying technologies, with the next generation of mobile standards known as 5G in the queue. . . . → Read More: Infographic – U.S. Falling Way Behind on 5G One comment - (Comments are closed) New products, Regulations computer science, economics, engineering, investment, software 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments Comments are closed Finance, Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, stem cells, university, venture capital 
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, investment, life sciences, pharmaceuticals 
Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry? . . . → Read More: Infographic – Harvard or Stanford? Venture Capitalists Revealed. 
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled 2 comments - (Comments are closed) Finance, Intellectual property biomedical, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital 
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, clinical trials, equity, Europe, genomics, investment, life sciences, medical device, pharmaceuticals, U.K. 
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests One comment - (Comments are closed) Finance biomarkers, biomedical, genomics, grant, investment, life sciences 
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds 2 comments - (Comments are closed) Finance biomedical, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled One comment - (Comments are closed) Finance biomedical, entrepreneurs, equity, Europe, investment, life sciences, U.K., venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
